Provention bio announces the grant of inducement awards

Red bank, n.j., jan. 7, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options to randy anderson, senior vice president of biometrics to purchase an aggregate of 130,000 shares of common stock.
PRVB Ratings Summary
PRVB Quant Ranking